Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Otsuka Holdings Co ( (JP:4578) ) has provided an update.
Otsuka Holdings Co., Ltd. has revised its financial forecast for the first half of FY2025, projecting higher revenues and profits due to strong performance in its pharmaceutical and nutraceutical sectors. Despite the yen’s appreciation, key products like Rexulti and POCARI SWEAT have driven growth, and lower-than-expected expenses have contributed to the favorable outlook.
The most recent analyst rating on (JP:4578) stock is a Buy with a Yen10400.00 price target. To see the full list of analyst forecasts on Otsuka Holdings Co stock, see the JP:4578 Stock Forecast page.
More about Otsuka Holdings Co
Otsuka Holdings Co., Ltd. operates in the pharmaceutical and nutraceutical industries, focusing on products such as antipsychotic drugs and health beverages. The company is listed on the Tokyo Stock Exchange and is known for its innovative healthcare solutions.
YTD Price Performance: -17.20%
Average Trading Volume: 1,449,033
Technical Sentiment Signal: Buy
Current Market Cap: Yen3725.1B
See more data about 4578 stock on TipRanks’ Stock Analysis page.